Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience | Zendy

Panagiotis Samaras | Zendy; Marcel Blickenstorfer | Zendy; Sarah R. Haile | Zendy; Daniele Siciliano | Zendy; Ulf Petrausch | Zendy; Axel Mischo | Zendy; Martin Zweifel | Zendy; Hanspeter Honegger | Zendy; Urs Schanz | Zendy; Georg Stüssi | Zendy; Ch. Taverna | Zendy; Stefan Bauer | Zendy; Alexander Knuth | Zendy; Frank Stenner | Zendy; Christoph Renner | Zendy

Open Access

Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience

Author(s) -

Panagiotis Samaras,

Marcel Blickenstorfer,

Sarah R. Haile,

Daniele Siciliano,

Ulf Petrausch,

Axel Mischo,

Martin Zweifel,

Hanspeter Honegger,

Urs Schanz,

Georg Stüssi,

Ch. Taverna,

Stefan Bauer,

Alexander Knuth,

Frank Stenner,

Christoph Renner

Publication year - 2011

Publication title -

schweizerische medizinische wochenschrift

Language(s) - English

Resource type - Journals

ISSN - 0036-7672

DOI - 10.4414/smw.2011.13203

Subject(s) - medicine , autologous stem cell transplantation , multiple myeloma , confidence interval , transplantation , population , surgery , chemotherapy , oncology , environmental health

ASCT is a safe and effective treatment mode in eligible patients with MM. TRM was below average at our institution. Achievement of CR after transplantation was the most valuable predictor for improved overall survival

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research